Average Co-Inventor Count = 4.58
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Millennium Pharmaceuticals Limited (26 from 850 patents)
2. Blueprint Medicines Corporation (6 from 60 patents)
3. Takeda Pharmaceutical Company Limited (1,179 patents)
32 patents:
1. 11634422 - Inhibitors of activin receptor-like kinase
2. 11236086 - Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
3. 10774070 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
4. 10538533 - Heteroaryls and uses thereof
5. 10233186 - Inhibitors of activin receptor-like kinase
6. 10227329 - Compounds useful for treating disorders related to RET
7. 10202365 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
8. 10202373 - Heteroaryls and uses thereof
9. 10202389 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
10. 10035811 - Derivatives of 1-amino-2-cyclobutylethylboronic acid
11. 9802960 - Heteroaryls and uses thereof
12. 9796725 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
13. 9771381 - Derivatives of 1-amino-2-cyclobutylethylboronic acid
14. 9751854 - Heteroaryls and uses thereof
15. 9663525 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme